iNCOVACC: First Intranasal COVID-19 Vaccine

• November 22, 2023
• By admin

• civiljudgeexam
• clat
• clat2024
• latinmaxims

iNCOVACC: First Intranasal COVID-19 Vaccine

• There are different methods of vaccine administration- Oral, Intradermal, subcutaneous, and intramuscular. But the Bharat Biotech recently launched an intranasal vaccine to treat COVID-19. It is called iNCOVACC. Intra-nasal means the vaccine is administered through nose. India has approved the vaccine and it is to be administered as a booster dose.

About iNCOVACC

• Two doses have been advised. The doses are to be administered within a time gap of 28 days
• Adeno Virus is the carrier of iNCOVACC, meaning, the antigen from Coronavirus is isolated and injected into the Adeno virus. This is done to increase the immunity power of the human body. The vaccines injected into the human body teach the immune system to fight against the virus. The carrier viruses aid in increases this fighting levels
• iNCOVACC is easy to deliver. Because; no needles or syringes are used in administering the vaccine
• Vaccine administration requires no skilled professionals.